High-Pressure Processing Unlocks Potent Blood Pressure-Lowering Peptides from Quinoa Protein

High hydrostatic pressure (HHP) at 300 MPa combined with Alcalase enzyme digestion produced the most potent quinoa protein hydrolysates. These showed the highest ACE-inhibitory activity (anti-hypertensive potential), enhanced antioxidant activity, and 1.8-fold increase in total flavonoids compared to non-hydrolyzed quinoa protein isolate. Three specific peptide sequences — GSHWPFGGK, FSIAWPR, and PWLNFK — had the highest Peptide Ranker scores and were predicted to have ACE-inhibitory, DPP-IV inhibitory, and antioxidant activities. Pressure at 300-400 MPa caused more extensive protein breakdown than enzyme alone.

Quinoa protein isolate was subjected to enzymatic hydrolysis with Alcalase at different high hydrostatic pressure levels (200, 300, 400 MPa) and compared to non-pressurized hydrolysis and non-hydrolyzed controls. Products were analyzed by SDS-PAGE, degree of hydrolysis, phenolic content, antioxidant assays, ACE inhibition assays, and peptide sequencing with Peptide Ranker prediction of bioactivity.

This study demonstrates a novel food processing technique (high-pressure-assisted enzymatic hydrolysis) that can significantly boost the bioactive peptide content of quinoa — a protein-rich grain increasingly popular in Western diets. The resulting peptides showed blood-pressure-lowering and antioxidant potential, suggesting quinoa protein hydrolysates could become functional food ingredients.

The functional food industry is increasingly looking beyond dairy (the traditional source of ACE-inhibitory peptides like lactotripeptides) toward plant proteins. Quinoa is particularly attractive because it's a complete protein source (all essential amino acids) and is already popular among health-conscious consumers. This study shows that processing matters — simple cooking doesn't release these bioactive peptides, but high-pressure enzymatic hydrolysis does. As food technology advances, 'heart-healthy quinoa protein hydrolysate' could become a supplement ingredient.

This is entirely an in vitro food chemistry study. The ACE-inhibitory and DPP-IV inhibitory activities were measured in lab assays, not in living organisms. Whether the identified peptides survive human digestion and absorption intact is unknown. Peptide Ranker predictions are computational — not experimental validation of bioactivity. The study doesn't address taste, palatability, or practical food formulation.